Advertisement

PharmacoEconomics

, Volume 11, Issue 5, pp 491–491 | Cite as

Interferon-α in Hepatitis C

  • Raymond S. Koff
Correspondence
  • 10 Downloads

Keywords

Hepatocellular Carcinoma Chronic Hepatitis Variceal Bleeding Chronic Active Hepatitis Hepatocellular Carci 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Briggs A, Shiell A. Interferon-α in hepatitis C: dosage, costs and benefits. Pharmacoeconomics 1996; 10(3): 205–9PubMedCrossRefGoogle Scholar
  2. 2.
    Nishiguchi S, Kuroki T, Morimoto H, et al. Randomised trial of effects of interferon-α on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet 1995; 346: 1051–55PubMedCrossRefGoogle Scholar

Copyright information

© Adis International Limited 1997

Authors and Affiliations

  • Raymond S. Koff
    • 1
  1. 1.Department of MedicineColumbia MetroWest Medical CenterFraminghamUSA

Personalised recommendations